FMP

FMP

Enter

DGX - Quest Diagnostics In...

Financial Summary of Quest Diagnostics Incorporated(DGX), Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United

photo-url-https://financialmodelingprep.com/image-stock/DGX.png

Quest Diagnostics Incorporated

DGX

NYSE

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

136.7 USD

6.61 (4.84%)

About

ceo

Mr. James E. Davis

sector

Healthcare

industry

Medical - Diagnostics & Research

website

https://www.questdiagnostics.com

exchange

NYSE

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient se...

CIK

0001022079

ISIN

US74834L1008

CUSIP

74834L100

Address

500 Plaza Drive

Phone

973 520 2700

Country

US

Employee

40,000

IPO Date

Dec 17, 1996

Summary

CIK

0001022079

Exchange

NYSE

Industry

Medical - Diagnostic...

Sector

Healthcare

CUSIP

74834L100

ISIN

US74834L1008

Country

US

Price

136.7

Beta

0.89

Volume Avg.

1.05M

Market Cap

15.13B

Shares

-

52-Week

119.59-148.62

DCF

196.79

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

18.25

P/B

-

Website

https://www.questdiagnostics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest DGX News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep